Contact
Please use this form to send email to PR contact of this press release:
TearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5%
TO:
Please use this form to send email to PR contact of this press release:
TearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5%
TO: